Chemoinformaics analysis of Citronellyl formate
| Molecular Weight | 184.279 | nRot | 7 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 13 |
| Exact Molecular Weight | 184.146 | nRing | 0 |
| Solubility: LogS | -4.164 | nHRing | 0 |
| Solubility: LogP | 3.225 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 33.3099 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.643 |
| Synth | 4.021 |
| Natural Product Likeliness | 2.623 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.553 |
| MDCK | 0.0000265 |
| BBB | 0.954 |
| PPB | 0.900425 |
| VDSS | 1.078 |
| FU | 0.0647553 |
| CYP1A2-inh | 0.2 |
| CYP1A2-sub | 0.738 |
| CYP2c19-inh | 0.12 |
| CYP2c19-sub | 0.936 |
| CYP2c9-inh | 0.291 |
| CYP2c9-sub | 0.472 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.529 |
| CYP3a4-inh | 0.071 |
| CYP3a4-sub | 0.485 |
| CL | 19.885 |
| T12 | 0.263 |
| hERG | 0.017 |
| Ames | 0.015 |
| ROA | 0.543 |
| SkinSen | 0.049 |
| Carcinogencity | 0.058 |
| EI | 0.068 |
| Respiratory | 0.355 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.733446 |